This inventor holds 1 USPTO granted patent. Top assignee: Chemagis Ltd.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: Michal Hasson: Innovator in Letrozole Purification
Introduction
Michal Hasson is a notable inventor based in Beersheba, Israel. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of letrozole, a medication used in the treatment of breast cancer. His innovative approach has led to the development of a unique purification process that enhances the quality of letrozole products.
Latest Patents
Hasson's most recent patent focuses on a purification process for letrozole that effectively removes isoletrozole impurities. The process involves converting a portion of the isoletrozole impurity into 4,4'-dicyanobenzophenone and subsequently removing this compound to yield a purified letrozole product. This advancement is crucial for ensuring the efficacy and safety of letrozole in medical applications. He holds 1 patent for this innovative process.
Career Highlights
Throughout his career, Michal Hasson has been associated with Chemagis Ltd., where he has played a pivotal role in research and development. His work has not only contributed to the company's success but has also advanced the pharmaceutical industry’s understanding of letrozole purification.
Collaborations
Hasson has collaborated with talented professionals such as Hila Isenberg and Efrat Manoff. These partnerships have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Michal Hasson is a distinguished inventor whose work in letrozole purification has made a significant impact in the pharmaceutical field. His dedication to innovation continues to drive advancements in medication safety and efficacy.